| 2025-11-24 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.86美元,归母净利润1.40亿美元,同比去年增长-42.84%
|
| 2025-11-24 |
财报披露：
美东时间 2025-11-24 盘前发布财报
|
| 2025-08-20 |
详情>>
股本变动：
变动后总股本16521.90万股
|
| 2025-08-20 |
详情>>
业绩披露：
2025年中报每股收益0.55美元,归母净利润8858.60万美元,同比去年增长-59.72%
|
| 2025-05-22 |
详情>>
业绩披露：
2025年一季报每股收益0.25美元,归母净利润4077.20万美元,同比去年增长-73.29%
|
| 2025-04-23 |
股东大会：
将于2025-05-22召开股东大会
会议内容 ▼▲
- 1.Presentation of the annual accounts of the Company for the financial year ended December 31, 2024 (the 2024 Financial Year), of the consolidated financial statements for the 2024 Financial Year as well as the management report and independent auditor’s report for the 2024 Financial Year.
2.Approval of the Financial Statements and the management report and acknowledgement of the independent auditor’s report.
3.Allocation of results for the 2024 Financial Year.
4.Discharge (quitus) of the members of the Board for the exercise of their mandate for the 2024 Financial Year.
5.Approval, authorization and, to the extent necessary, ratification of the remuneration of the members of the Board.
6.Appointment of the independent auditor (cabinet de révision agréé) for the financial year ending December 31, 2025.
|
| 2025-03-27 |
详情>>
业绩披露：
2022年年报每股收益1.05美元,归母净利润1.68亿美元,同比去年增长242.81%
|
| 2025-03-27 |
详情>>
业绩披露：
2024年年报每股收益1.76美元,归母净利润2.83亿美元,同比去年增长18.02%
|
| 2024-11-20 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.52美元,归母净利润2.45亿美元,同比去年增长65.96%
|
| 2024-08-21 |
详情>>
业绩披露：
2024年中报每股收益1.37美元,归母净利润2.20亿美元,同比去年增长115.38%
|
| 2024-05-22 |
详情>>
业绩披露：
2024年一季报每股收益0.94美元,归母净利润1.53亿美元,同比去年增长381.84%
|
| 2024-04-22 |
股东大会：
将于2024-05-22召开股东大会
会议内容 ▼▲
- 1.Presentation of the annual accounts of the Company for the financial year ended December 31, 2023 (the 2023 Financial Year), of the consolidated financial statements for the 2023 Financial Year as well as the management report and independent auditor's report for the 2023 Financial Year.
2.Approval of the Financial Statements and the management report and acknowledgement of the independent auditor's report.
The Board proposes to the Meeting to approve the Financial Statements, the management report and acknowledge the report of the independent auditor relating thereto in accordance with article 461-7 of the Luxembourg Act on Commercial Companies dated August 10, 1915, as amended (the Companies Act).
3.Allocation of results for the 2023 Financial Year.
The Board proposes to the Meeting to acknowledge that the Company has made a profit with respect to the 2023 Financial Year in an aggregate amount of US$ 74,857,371.41 (the Profit).
The Board proposes to the Meeting to allocate 5% of the Profit made during the 2023 Financial Year and therefore to allocate an amount of US$ 3,742,868.58 to the legal reserve, in accordance with article 461-1 of the Companies Act.
The Board proposes to set-off the losses brought forward incurred by the Company during the previous financial years in an amount of US$ 36,967,419.60 against part of the Profit and carry forward the remainder of the Profit in an amount of US$ 34,147,083.23 to the next financial year.
4.Discharge (quitus) of the members of the Board for the exercise of their mandate for the 2023 Financial Year.
The Board proposes to the Meeting to grant discharge (quitus) to the members of the Board for the performance of their duties as members of the Board for, and in connection with, the 2023 Financial Year.
5.Approval, authorization and, to the extent necessary, ratification of the remuneration of the members of the Board.
The Board proposes to the Meeting to approve, authorize and, to the extent necessary, ratify the gross remuneration for the members of the Board, for the performance of their duties in connection with their mandate as directors of the Company during the 2023 Financial Year, to an aggregate amount of EUR 396,333.33.
6.Appointment of the independent auditor (cabinet de revision agree) for the financial year ending December 31, 2024.
The Board proposes to the Meeting to appoint PricewaterhouseCoopers as independent auditor (cabinet de revision agree) for the establishment of the annual accounts and consolidated financial statements of the Company for the financial year ending December 31, 2024, and to grant power and authority to the Board to enter into the relevant agreement (in accordance with market standards) with PricewaterhouseCoopers.
|
| 2024-03-28 |
详情>>
业绩披露：
2023年年报每股收益1.49美元,归母净利润2.40亿美元,同比去年增长42.42%
|
| 2023-11-15 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.92美元,归母净利润1.48亿美元,同比去年增长-8.08%
|
| 2023-04-24 |
股东大会：
将于2023-05-23召开股东大会
会议内容 ▼▲
- 1.Presentation of the annual accounts of the Company for the financial year ended December 31, 2022 (the 2022 Financial Year), of the consolidated financial statements for the 2022 Financial Year as well as the management report and independent auditor’s report for the 2022 Financial Year.
2.Approval of the Financial Statements and the management report and acknowledgement of the independent auditor’s report.
3.Allocation of results for the 2022 Financial Year.
4.Discharge (quitus) of the members of the Board for the exercise of their mandate for the 2022 Financial Year.
5.Appointment of the members of the Board for a mandate which will end at the occasion of the approval of the annual accounts of the Company for the financial year ending on December 31, 2025
6.Approval, authorization and, to the extent necessary, ratification of the remuneration of the members of the Board.
7.Approval, authorization and, to the extent necessary, ratification of the renewal and amendment of the directors’ compensation policy setting out the compensation system for the current and future directors of the Company (the Directors’ Compensation Policy).
8.Appointment of the independent auditor (cabinet de revision agree) for the financial year ending December 31, 2023.
9.Renewal of the authorised share capital of the Company.
10.Amendment of the number of executive committee (comite de direction) members of the Company.
11.Amendment to the signatory powers in respect of the daily management.
12.Amendment of the term “chairman” to “chairperson” in the Articles
|
| 2022-05-02 |
股东大会：
将于2022-05-31召开股东大会
会议内容 ▼▲
- 1.Presentation of the annual accounts of the Company for the financial year ended December 31, 2021 (the 2021 Financial Year), of the consolidated financial statements for the 2021 Financial Year as well as the management report and independent auditor’s report for the 2021 Financial Year.
2.Approval of the Financial Statements and the management report and acknowledgement of the independent auditor’s report.
3.Allocation of results for the 2021 Financial Year.
4.Discharge (quitus) of the members of the Board for the exercise of their mandate for the 2021 Financial Year.
5.Approval, authorization and, to the extent necessary, ratification of the remuneration of the members of the Board.
6.Appointment of the independent auditor (cabinet de révision agréé) for the financial year ending December 31, 2022.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-20 |
股东大会：
将于2021-05-20召开股东大会
会议内容 ▼▲
- 1.Presentation of the annual accounts of the Company for the financial year ended December 31, 2020 (the 2020 Financial Year), of the consolidated financial statements for the 2020 Financial Year as well as the management report and independent auditor’s report for the 2020 Financial Year.
2.Approval of the Financial Statements and the management report and acknowledgement of the independent auditor’s report.
3.Allocation of results for the 2020 Financial Year.
4.Discharge (quitus) of the members of the Board for the exercise of their mandate for the 2020 Financial Year.
5.Approval, authorization and, to the extent necessary, ratification of the remuneration of the members of the Board.
6.Appointment of the independent auditor (cabinet de révision agréé) for the financial year ending December 31, 2021.
|
| 2020-12-01 |
复牌提示：
2020-12-01 10:26:46 停牌，复牌日期 2020-12-01 10:31:52
|
| 2020-04-20 |
股东大会：
将于2020-05-20召开股东大会
会议内容 ▼▲
- 1.Presentation of the annual accounts of the Company for the financial year ended December 31, 2019 (the 2019 Financial Year), of the consolidated financial statements for the 2019 Financial Year as well as the management report and independent auditor’s report for the 2019 Financial Year.
2.Approval of the Financial Statements and the management report and acknowledgement of the independent auditor’s report.
3.Allocation of results for the 2019 Financial Year.
4.Discharge (quitus) of the members of the Board for the exercise of their mandate for the 2019 Financial Year.
5.Approval, authorization and, to the extent necessary, ratification of the remuneration of the members of the Board.
6.Approval, authorization and, to the extent necessary, ratification of the directors’ compensation policy setting out the compensation system for the current and future directors of the Company (the Director’s Compensation Policy)
7.Appointment of the independent auditor (cabinet de révision agréé) for the financial year ending December 31, 2020.
|
| 2019-04-22 |
股东大会：
将于2019-05-22召开股东大会
会议内容 ▼▲
- 1.Presentation of the annual accounts of the Company for the financial year ended December 31, 2018 (the 2018 Financial Year), of the consolidated financial statements for the 2018 Financial Year as well as the management report and independent auditor’s report for the 2018 Financial Year.
2.Approval of the Financial Statements and the management report and acknowledgement of the independent auditor’s report.
3.Allocation of results for the2018 Financial Year.
4.Discharge (quitus) of the members of the Board for the exercise of their mandate for the 2018 Financial Year.
5.Authorization of the remuneration of the members of the Board.
6.Confirmation of the appointment of Mr. Daniel Marx as new member of the Board
7.Appointment of the independent auditor (cabinet de revision agree) for the financial year ending December 31, 2019.
8.Authorisation to the Board to implement a share repurchase program
9.Amendment of the convening procedure for general meetings of the shareholders to take into account NYSE convening requirements
10.Amendment of the signature power to sign extracts or copies of minutes of General Meetings
11.Amendment of the convening procedure for meetings of the Board
12.Amendment of the signature power to sign extracts or copies of minutes of meetings of the Board
13.Amendment of the period during which certain documents shall remain available at the registered office of the Company prior to General Meetings
14.Amendment of the Articles to adjust a clerical inaccuracy and add a definition of “General Meeting”
|
| 2018-04-30 |
股东大会：
将于2018-05-30召开股东大会
会议内容 ▼▲
- 1.approval of the financial statements and the management report and acknowledgement of the independent auditor's report.
2.allocation of results for 2017 financial year.
3.authorization of the remuneration of the members of the board .
|